@WHO: To address the pricing and access issues, WHO and @Unitaid are negotiating with manufacturers for lower prices and equitable distribution. WHO is also in talks with partners for a donation and distribution of the drug through @UNICEF, following allocation criteria set by WHO. https://t.co/QWhFVEsjE4

http://twitter.com/WHO
via IFTTT